Central nervous system repair and therapeutic vaccination

( views:, downloads: )
JIANG Xiao-dan()
XIAO Zhi-cheng()
Journal Title:
Volume 6, Issue 03, 2007
Key Word:


  • [1]Raineteau O,Schwab ME.Plasticity of motor systems after incomplete spinal cord injury[J].Nat Rev Neurosci,2001,2 (4):263-273.
  • [2]Ang BT,Xu G,Xiao ZC.Therapeutic vaccination for central nervous system[J].Clin Exp Pharmacol Physol,2006,33 (5-6):567-571.
  • [3]Xu G,Nie DY,Wang WZ,et al.Optic nerve regeneration in polyglycolic acid-chitosan conduits coated with recombinant L1-Fc[J].Neuroreport,2004,15(14):2167-2172.
  • [4]Chen MS,Huber AB,van der Haar ME,et al.Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigent for monoclonal antibody IN-1[J].Nature,2000,403(6768):433-439.
  • [5]Domeniconi M,Cao Z,Spencer T,et al.Myelin-associated glycoprotein interacts with the Nogo-66 receptor to inhibit neurite outgrowth[J].Neuron,2002,35(2):283-290.
  • [6]Yamashita T,Higuchi H,Tohyama M.The p75 receptor transduces the signal from myelin-associated glycoprotein to Rho[J].J Cell Biol,2002,157(4):565-570.
  • [7]Kottis V,Thibault P,Mikol D,et al.Oligodendrocyte-myelin glycoprotein is an inhibitor of neurite outgrowth[J].J Neurochem,2002,82(6):1566-1569.
  • [8]Liao H,Bu WY,Wang TH,et al.Tenascin-R plays a role in neuroprotection via its distinct domains that coordinate to modulate the microglia function[J].J Biol Chem,2005,280(9):8316-8323.
  • [9]Nie DY,Zhou ZH,Ang BT,et al.Nogo-A at CNS paranodes is a ligand of caspr:possible regulation of K(+) channel localization[J].FMBO J,2003,22(21):5666-5678.
  • [10]Bracken MB,Shepard MJ,Holford TR,et al.Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48hours in the treatment of acute spinal cord injury.Results of the third national acute spinal cord injury randomized controlled trial.National acute spinal cord injury study[J].JAMA,1997,277(20):1597-1604.
  • [11]Hauben F,Butovsky O,Nevo U,et al.Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion[J].J Neurosci,2000,20(17):6421-6430.
  • [12]Kipnis J,Yoles E,Schori H,et al.Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response[J].J Neurosci,2001,21(13):4564-4571.
  • [13]Kipnis J,Mizrahi T,Yoles E,et al.Myelin specific Thl cells are necessary for post-traumatic protective autoiinmunity[J].J Neuroimmunol,2002,130(1-2):78-85.
  • [14]Popovich PG,Jones TB.Manipulating the neuroinflammatory reactions in the injured spinal cord:back to basics[J].Trends Pharmacol Sci,2003,24(1):13-17.
  • [15]Papadopoulos CM,Tsai SY,Alsbici T,et al.Functional recovery and neuroanatomical plasticity following middle cerebral artery occlusion and IN-1 antibody treatment in the adult rat[J].Ann Neurol,2002,51(4):433-441.
  • [16]Huang DW,McKerracher L,Braun PE,et al.A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord[J].Neuron,1999,24(3):639-647.
  • [17]Sicotte M,Tsatas O,Jeong SY,et al.Immunization with myelin or recombinant Nogo-66/MAG in alum promote axon regeneration and sprouting after corticospinal tract lesions in the spinal cord[J].Mol Cell Neurosci,2003,23(2):251-263.
  • [18]Xu G,Nie DY,Chen JT,et al.Recombinant DNA vaccine encoding multiple domains related to inhibition of neurite outgrowth:a potential strategy for axonal regeneration[J].J Neurochem,2004,91 (4):1018-1023.
  • [19]Kamezis T,Mandemakers W,Mcqualter JL,et al.Theneurite outgrowth inhibitor Nogo A is involved in autoimmnne-mediated demyelination[J].Nat Neurosci,2004,7(7):736-744.
  • [20]Masliah E,Rockenstein E,Adame A,et al.Effects of α-synuclein immunization in a mouse model of Parkinson's disease[J].Neuron,2005,46(6):857-868.
  • [21]Kipris J,Nevo U,Panikashvili D,et al.Therapeutic vaccination for closed head injury[J].J Neurotrauma,2003,20(6):559-569.
  • [22]Angelov DN,Waibel S,Guntimas-Lichius O,et al.Therapeutic vaccine for acute and chronic motor neuron diseases:implications for amyotrophic lateral sclerosis[J].Proc Nal Acad Sci USA,2003,100(8):4790-4795.
  • [23]Schwartz M.Neurodegeneration and neuroprotection in glaucoma:development of a therapeutic neuroprotective vaccine.The Friedenwald lecture[J].Invest Ophthamol Vis Sci,2003,44 (4):1407-1411.
  • [24]Avidan H,Kipnis J,Butovsky O,et al.Vaccination with autoantigen against aggregated-amyloid and glutamate taxicity by controlling microglia:effect of CD4+CD25+ T cells[J].Eur J Immunol,2004,34(12):3434-3445.
  • [25]Benner EJ,Mosley RL,Destache CJ,et al.Trherapeutic immunization protects dopaminergic neurons in a mouse model of Pakinson's disease[J].Proc Natl Acad Sci USA,2004,101 (25):9435-9440.
  • [26]Kipnis J,Schwartz M.Dual action ofglatiramer acetate (Cop-1) in the treatment ofCNS autoimmune and neurodegenerative disorders[J].Trends Mol Med,2002,8(7):319-323.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn